Cargando…
Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
Reducing the long-term morbidity in testicular cancer survivors represents a major area of interest. External beam radiation therapy and systemic chemotherapy are established treatments for seminoma; however, they are associated with late toxicities such as cardiovascular disease, insulin resistance...
Autores principales: | Hu, Brian, Daneshmand, Siamak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816883/ https://www.ncbi.nlm.nih.gov/pubmed/29487620 http://dx.doi.org/10.1155/2018/7978958 |
Ejemplares similares
-
Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
por: Alsyouf, Muhannad, et al.
Publicado: (2023) -
The role of primary retroperitoneal lymph node dissection in the treatment of stage II seminoma
por: Sigg, Silvan, et al.
Publicado: (2023) -
Laparoscopic retroperitoneal lymph node dissection for testicular cancer
por: Hillelsohn, Joel H., et al.
Publicado: (2012) -
Retroperitoneal lymph node dissection for germ cell tumour
por: Tran, Vy, et al.
Publicado: (2020) -
Outpatient robotic assisted retroperitoneal lymph node dissection
por: Basourakos, Spyridon P., et al.
Publicado: (2022)